Tenosynovial Giant Cell Tumor
ICD-10 M12.2 · ICD-11 FA27.1

Treatment of Localized Tenosynovial Giant Cell Tumor

This protocol addresses the management of localized tenosynovial giant cell tumor (L-TGCT) — a well-demarcated, nodular form of the condition with specific anatomical characteristics that shape the treatment approach.

Localized TGCT presents as a distinct, nodular lesion. Studies show that L-TGCT affects the digits in the vast majority of patients, typically appearing as a single nodule with sharply defined margins.
The management of localized TGCT centres on a targeted surgical intervention. The sharply defined margins of L-TGCT are a key factor in guiding the operative strategy — full details, including the specific procedure and clinical decision points, are in the complete protocol.
Complete regimen available via the link below.

References

DOI: 10.56875/2589-0646.1032

  • L-TGCT shows single nodules affecting the digits in 85% of patients.
  • Traditionally, the surgical approach for L-TGCT and D-TGCT involves marginal excision and total synovectomy, respectively.
  • Localized TGCT has distinct and sharp margins that allow for sufficient macroscopic complete resection.
View source ↗